<- Go Home
PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Market Cap
$3.7B
Volume
567.6K
Cash and Equivalents
$196.8M
EBITDA
-$101.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$114.7M
Profit Margin
57.39%
52 Week High
$103.81
52 Week Low
$45.20
Dividend
N/A
Price / Book Value
14.62
Price / Earnings
-34.68
Price / Tangible Book Value
14.68
Enterprise Value
$3.5B
Enterprise Value / EBITDA
-37.64
Operating Income
-$106.5M
Return on Equity
37.02%
Return on Assets
-16.73
Cash and Short Term Investments
$196.8M
Debt
$82.6M
Equity
$241.2M
Revenue
$199.8M
Unlevered FCF
-$80.1M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium